Sg3 Management, LLC Clovis Oncology, Inc. Put Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$4.82 - $7.72 $192,800 - $308,800
-40,000 Closed
0 $0
Q1 2020

May 12, 2020
BUY
$3.77 - $11.0 $150,800 - $440,000
40,000 New
40,000 $254,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email